Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.23.3
Stock-Based Compensation (Tables)
 9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Nonvested Restricted Stock Units Activity
The summary of RSU activity is as follows (in thousands, except per share data):
Number of Units Weighted-Average Grant Date Fair Value Per Share Aggregate Intrinsic Value (in thousands)
Balances—December 31, 2022
 28,537,127 $ 5.75  $ 95,599 
Granted 12,180,784 $ 6.52   
Vested (9,614,245) $ 5.02   
Forfeited (1,761,105) $ 6.08   
Balances—September 30, 2023
 29,342,561 $ 6.28  $ 189,260 
Summary of Stock-Based Compensation Expense
The following sets forth the total stock-based compensation expense for the Company’s stock awards included in the Company’s condensed consolidated statements of operations (in thousands):
Three Months Ended September 30, Nine Months Ended September 30,
2023 2022 2023 2022
Research and development expenses $ 21,455  $ 9,409  $ 54,657  $ 37,519 
Selling, general and administrative expenses 5,812  3,634  15,090  14,386 
Total stock-based compensation expense $ 27,267  $ 13,043  $ 69,747  $ 51,905